Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant [Phase 1]

View source ↗

Summary

Vivani Medical is conducting a Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of a subcutaneous semaglutide implant for obesity; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Semaglutide implant (semaglutide)

Snippet

Sponsor: Vivani Medical, Inc | Conditions: Obesity & Overweight | Phase 1 | Status: NOT_YET_RECRUITING